Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$1.2M
Net $954.5K sold
Sales
$954.5K
1 transaction
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Paolini John F.
- Role
- Insider
- Location
- LONDON, X0
Filing Details
- Filing Date
- Aug 8, 2025
- Transaction Date
- Aug 6, 2025
- Accession Number
- 0001415889-25-021346
- Form Type
- 4
- Net Trading Amount
- -$954.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 6, 2025 | Class A Ordinary Share | 29,325 | $3.80 | Exercise | $111.4K |
| Aug 6, 2025 | Class A Ordinary Share | 29,325 | $32.55 | Sale | $954.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Aug 6, 2025 | Derivative | 29,325 | $3.80 | Exercise | $111.4K |
Footnotes
- (F1)This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 16, 2024.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.13 and $33.08. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)The option is fully vested and exercisable.